Literature DB >> 11968083

Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred.

Carla Oliveira1, Maria Cristina Bordin, Nicola Grehan, David Huntsman, Gianpaolo Suriano, José Carlos Machado, Tuula Kiviluoto, Lauri Aaltonen, Charles E Jackson, Raquel Seruca, Carlos Caldas.   

Abstract

The International Gastric Cancer Linkage Consortium (IGCLC) predicted that up to 25% of families fulfilling the criteria for hereditary diffuse gastric cancer (HDGC) would harbor CDH1 germline mutations. This was based on observations from the low number of diffuse gastric cancer families described at the time, and its validation would require analysis of larger numbers. Here we report the results of germline CDH1 mutation screening in 39 kindred with familial aggregation of gastric cancer, a subset of which fulfills the criteria defined by the IGCLC for HDGC. CDH1 germline mutations were detected in four of 11 (36.4%) HDGC families. No mutations were identified in 63.6% of HDGC families or in kindred with familial aggregation of gastric cancer not fulfilling criteria for HDGC. These results add support to the evidence that only HDGC families harbor germline mutations in CDH1 and that genes other than CDH1 remain to be identified. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11968083     DOI: 10.1002/humu.10068

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  47 in total

Review 1.  Biomarkers and molecular diagnosis of gastrointestinal and pancreatic neoplasms.

Authors:  Shelby D Melton; Robert M Genta; Rhonda F Souza
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-05       Impact factor: 46.802

Review 2.  A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer.

Authors:  Rajini Seevaratnam; Natalie Coburn; Roberta Cardoso; Matthew Dixon; Alina Bocicariu; Lucy Helyer
Journal:  Gastric Cancer       Date:  2011-12-10       Impact factor: 7.370

3.  Familial gastric cancers with Li-Fraumeni Syndrome: a case repast.

Authors:  Il-Jin Kim; Hio-Chung Kang; Yong Shin; Byong-Chul Yoo; Han-Kwang Yang; Jae-Gahb Park
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

4.  CDH1/E-cadherin germline mutations in early-onset gastric cancer.

Authors:  J T Bacani; M Soares; R Zwingerman; N di Nicola; J Senz; R Riddell; D G Huntsman; S Gallinger
Journal:  J Med Genet       Date:  2006-06-26       Impact factor: 6.318

5.  Family history of gastric cancer correlates with decreased expression of HINT1 tumor suppressor gene in gastric mucosa of dyspeptic patients.

Authors:  Karolina Zuk; Lukasz Peczek; Krystyna Stec-Michalska; Marta Medrek; Barbara Nawrot
Journal:  Oncol Lett       Date:  2011-10-21       Impact factor: 2.967

Review 6.  Hereditary diffuse gastric cancer: What the clinician should know.

Authors:  Ryan Ying Cong Tan; Joanne Ngeow
Journal:  World J Gastrointest Oncol       Date:  2015-09-15

7.  Germline mutations in hereditary diffuse gastric cancer.

Authors:  Hao Zhang; Mengmeng Feng; Yi Feng; Zhaode Bu; Ziyu Li; Shuqin Jia; Jiafu Ji
Journal:  Chin J Cancer Res       Date:  2018-02       Impact factor: 5.087

8.  Genetic screening for familial gastric cancer.

Authors:  Carla Oliveira; Gianpaolo Suriano; Paulo Ferreira; Paulo Canedo; Pardeep Kaurah; Rita Mateus; Ana Ferreira; António C Ferreira; Maria José Oliveira; Céu Figueiredo; Fátima Carneiro; Gisela Keller; David Huntsman; José Carlos Machado; Raquel Seruca
Journal:  Hered Cancer Clin Pract       Date:  2004-05-15       Impact factor: 2.857

Review 9.  CDH1 germline mutation in hereditary gastric carcinoma.

Authors:  Hai-Dan Wang; Jun Ren; Lian Zhang
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

10.  A short guide to hereditary diffuse gastric cancer.

Authors:  Parry Guilford; Vanessa Blair; Helen More; Bostjan Humar
Journal:  Hered Cancer Clin Pract       Date:  2007-12-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.